Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full... (od screening manufacturing facili...)

HOME >> BIOLOGY >> TECHNOLOGY

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007

Date:2/13/2008

od screening

manufacturing facility located in Rancho Bernardo, California. The

Company had leased the 94,000-square-feet facility since late 1997.

The transaction is expected to have an immaterial effect on

Gen-Probe's income statement in 2008, but is expected to be accretive

to earnings over the long term, based on rent increases that would

have been associated with renewing the Company's lease. "The purchase

of our state-of-the-art blood screening manufacturing facility on

attractive financial terms reflects our long-term commitment to

providing innovative nucleic acid tests that safeguard the world's

supply of donated blood," said Mr. Hull.

Webcast Conference Call

A live webcast of Gen-Probe's fourth quarter 2007 conference call for investors can be accessed at http://www.gen-probe.com beginning at 4:30 p.m. Eastern Time today. The webcast will be archived for at least 90 days. A telephone replay of the call also will be available for approximately 24 hours. The replay number is (800) 308-7858 for domestic callers and (402) 220-3841 for international callers.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Trademarks

APTIMA, APTIMA COMBO 2, PACE and TIGRIS are trademarks of Gen-Probe. ULTRIO and P
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year

Post Your Comments:

Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full...(od screening manufacturing facili...)